Literature DB >> 19651771

Site-specific cleavage of BMP4 by furin, PC6, and PC7.

Sylvia M Nelsen1, Jan L Christian.   

Abstract

Bone morphogenetic proteins (BMPs) require proteolytic activation by members of the proprotein convertase (PC) family. Pro-BMP4 is initially cleaved at a site adjacent to the mature ligand domain (S1) and then at an upstream site (S2) within the prodomain. Cleavage at the S2 site, which appears to occur in a tissue-specific fashion, regulates the activity and signaling range of mature BMP4. To test the hypothesis that tissue-specific cleavage of pro-BMP4 is regulated by differential expression of a site-specific protease, we identified the PCs that cleave each site in vivo. In Xenopus oocytes, furin and PC6 function redundantly to cleave both the S1 and S2 sites of pro-BMP4, as evidenced by the results of antisense-mediated gene knockdown and the use of the furin- and PC6-selective inhibitor alpha(1)-PDX. By contrast, alpha(1)-PDX blocked cleavage of the S2 but not the S1 site of pro-BMP4 in embryos, suggesting the existence of a developmentally regulated S1 site-specific convertase. This protease is likely to be PC7 based on knowledge of its required substrate cleavage motif and resistance to alpha(1)-PDX. Consistent with this prediction, an alpha(1)-PDX variant engineered to target PC7, in addition to furin and PC6, completely inhibited cleavage of BMP4 in oocytes and embryos. Further studies showed that pc7 transcripts are expressed and polyadenylated, and that the PC7 precursor protein undergoes efficient autocatalytic activation in both oocytes and embryos. These results suggest that PC7, or a convertase with similar substrate specificity, functions to selectively cleave the S1 site of pro-BMP4 in a developmentally regulated fashion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651771      PMCID: PMC2785643          DOI: 10.1074/jbc.M109.028506

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  XPACE4 is a localized pro-protein convertase required for mesoderm induction and the cleavage of specific TGFbeta proteins in Xenopus development.

Authors:  Bilge Birsoy; Linnea Berg; P Huw Williams; James C Smith; Christopher C Wylie; Jan L Christian; Janet Heasman
Journal:  Development       Date:  2005-01-05       Impact factor: 6.868

2.  Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity.

Authors:  Devorah C Goldman; Renee Hackenmiller; Takuya Nakayama; Shailaja Sopory; Crispin Wong; Holger Kulessa; Jan L Christian
Journal:  Development       Date:  2006-04-19       Impact factor: 6.868

Review 3.  Palmitoylation: policing protein stability and traffic.

Authors:  Maurine E Linder; Robert J Deschenes
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

4.  Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain.

Authors:  Shailaja Sopory; Sylvia M Nelsen; Catherine Degnin; Crispin Wong; Jan L Christian
Journal:  J Biol Chem       Date:  2006-09-11       Impact factor: 5.157

5.  Proprotein convertase genes in Xenopus development.

Authors:  Sylvia Nelsen; Linnea Berg; Crispin Wong; Jan L Christian
Journal:  Dev Dyn       Date:  2005-07       Impact factor: 3.780

6.  VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5.

Authors:  Dorota Szumska; Guido Pieles; Rachid Essalmani; Michal Bilski; Daniel Mesnard; Kulvinder Kaur; Angela Franklyn; Kamel El Omari; Joanna Jefferis; Jamie Bentham; Jennifer M Taylor; Jurgen E Schneider; Sebastian J Arnold; Paul Johnson; Zuzanna Tymowska-Lalanne; Dave Stammers; Kieran Clarke; Stefan Neubauer; Andrew Morris; Steve D Brown; Charles Shaw-Smith; Armando Cama; Valeria Capra; Jiannis Ragoussis; Daniel Constam; Nabil G Seidah; Annik Prat; Shoumo Bhattacharya
Journal:  Genes Dev       Date:  2008-06-01       Impact factor: 11.361

7.  In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate.

Authors:  Rachid Essalmani; Ahmed Zaid; Jadwiga Marcinkiewicz; Ann Chamberland; Antonella Pasquato; Nabil G Seidah; Annik Prat
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

8.  Post-transcriptional regulation of Xwnt-8 expression is required for normal myogenesis during vertebrate embryonic development.

Authors:  Q Tian; T Nakayama; M P Dixon; J L Christian
Journal:  Development       Date:  1999-08       Impact factor: 6.868

9.  Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases.

Authors:  D B Constam; E J Robertson
Journal:  J Cell Biol       Date:  1999-01-11       Impact factor: 10.539

Review 10.  Translational control by cytoplasmic polyadenylation in Xenopus oocytes.

Authors:  Helois E Radford; Hedda A Meijer; Cornelia H de Moor
Journal:  Biochim Biophys Acta       Date:  2008-02-14
View more
  34 in total

1.  The proprotein convertase PC7: unique zymogen activation and trafficking pathways.

Authors:  Estelle Rousselet; Suzanne Benjannet; Josée Hamelin; Maryssa Canuel; Nabil G Seidah
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).

Authors:  Hannu Turpeinen; Anna Oksanen; Virpi Kivinen; Sampo Kukkurainen; Annemari Uusimäki; Mika Rämet; Mataleena Parikka; Vesa P Hytönen; Matti Nykter; Marko Pesu
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

3.  The microenvironment patterns the pluripotent mouse epiblast through paracrine Furin and Pace4 proteolytic activities.

Authors:  Daniel Mesnard; Martyn Donnison; Christophe Fuerer; Peter L Pfeffer; Daniel B Constam
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

Review 4.  Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Authors:  Imran H A Ali; Derek P Brazil
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

5.  The prodomain of BMP4 is necessary and sufficient to generate stable BMP4/7 heterodimers with enhanced bioactivity in vivo.

Authors:  Judith M Neugebauer; Sunjong Kwon; Hyung-Seok Kim; Nathan Donley; Anup Tilak; Shailaja Sopory; Jan L Christian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

6.  Simultaneous rather than ordered cleavage of two sites within the BMP4 prodomain leads to loss of ligand in mice.

Authors:  Anup Tilak; Sylvia M Nelsen; Hyung-Seok Kim; Nathan Donley; Autumn McKnite; Hyunjung Lee; Jan L Christian
Journal:  Development       Date:  2014-07-03       Impact factor: 6.868

7.  Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor.

Authors:  Estelle Rousselet; Suzanne Benjannet; Edwidge Marcinkiewicz; Marie-Claude Asselin; Claude Lazure; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 8.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

9.  Effects of imposed defocus of opposite sign on temporal gene expression patterns of BMP4 and BMP7 in chick RPE.

Authors:  Yan Zhang; Yue Liu; Carol Ho; Christine F Wildsoet
Journal:  Exp Eye Res       Date:  2013-02-19       Impact factor: 3.467

10.  Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.

Authors:  Katarina Hajdin; Valentina D'Alessandro; Felix K Niggli; Beat W Schäfer; Michele Bernasconi
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.